CN1095382A - 新的菁族a环甾族化合物 - Google Patents
新的菁族a环甾族化合物 Download PDFInfo
- Publication number
- CN1095382A CN1095382A CN93109540A CN93109540A CN1095382A CN 1095382 A CN1095382 A CN 1095382A CN 93109540 A CN93109540 A CN 93109540A CN 93109540 A CN93109540 A CN 93109540A CN 1095382 A CN1095382 A CN 1095382A
- Authority
- CN
- China
- Prior art keywords
- compound
- female
- triolefin
- formula
- carbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C[*-]c1ccc(C(CC2)C(CC3)C(CC4)[C@@]2(C)[C@]4C#N)c3c1 Chemical compound C[*-]c1ccc(C(CC2)C(CC3)C(CC4)[C@@]2(C)[C@]4C#N)c3c1 0.000 description 1
- PDSOIUHLYKBZLZ-VRSOYXCKSA-N C[C@](CC1)(C(CC2)C(CC3)C1c(cc1)c3cc1O)[C@H]2C#N Chemical compound C[C@](CC1)(C(CC2)C(CC3)C1c(cc1)c3cc1O)[C@H]2C#N PDSOIUHLYKBZLZ-VRSOYXCKSA-N 0.000 description 1
- DNXHEGUUPJUMQT-GUZDXLFXSA-N C[C@](CC1)(C(CC2)C(CCc3c4)C1c3ccc4O)C2=O Chemical compound C[C@](CC1)(C(CC2)C(CCc3c4)C1c3ccc4O)C2=O DNXHEGUUPJUMQT-GUZDXLFXSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929213835A GB9213835D0 (en) | 1992-06-30 | 1992-06-30 | Compounds |
GB9213835.3 | 1992-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1095382A true CN1095382A (zh) | 1994-11-23 |
Family
ID=10717920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN93109540A Pending CN1095382A (zh) | 1992-06-30 | 1993-06-30 | 新的菁族a环甾族化合物 |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0651643A4 (no) |
JP (1) | JPH08500821A (no) |
KR (1) | KR950702118A (no) |
CN (1) | CN1095382A (no) |
AP (1) | AP412A (no) |
AU (1) | AU4545993A (no) |
BG (1) | BG99313A (no) |
BR (1) | BR9306748A (no) |
CA (1) | CA2138956A1 (no) |
CZ (1) | CZ334694A3 (no) |
FI (1) | FI946189A (no) |
GB (1) | GB9213835D0 (no) |
HU (1) | HUT69409A (no) |
IL (1) | IL106158A0 (no) |
MA (1) | MA22927A1 (no) |
MX (1) | MX9303970A (no) |
NO (1) | NO945074L (no) |
OA (1) | OA10122A (no) |
RU (1) | RU94046378A (no) |
SI (1) | SI9300350A (no) |
SK (1) | SK159994A3 (no) |
WO (1) | WO1994000125A1 (no) |
ZA (1) | ZA934645B (no) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114805462A (zh) * | 2018-02-11 | 2022-07-29 | 江苏豪森药业集团有限公司 | 一种甾族类衍生物调节剂及其制备方法和应用 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925774A (en) | 1991-01-07 | 1999-07-20 | Pherin Corporation | Estrenes for inducing hypothalamic effects |
CA2135056A1 (en) * | 1992-05-20 | 1993-11-25 | Donald W. Graham | New delta-17 and delta-20 olefinic and saturated 17b-substituted-4-aza-5a-andros-tan-3-ones as 5a-reductase inhibitors |
US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
GB201102913D0 (en) | 2011-02-18 | 2011-04-06 | Univ Birmingham | Novel therapeutic |
JP2015129095A (ja) | 2013-12-19 | 2015-07-16 | ロレアル | 組成物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954446A (en) * | 1988-05-25 | 1990-09-04 | Smithkline Beecham Corporation | Aromatic steroid 5-α-reductase inhibitors |
-
1992
- 1992-06-30 GB GB929213835A patent/GB9213835D0/en active Pending
-
1993
- 1993-06-26 ZA ZA934645A patent/ZA934645B/xx unknown
- 1993-06-28 MA MA23217A patent/MA22927A1/fr unknown
- 1993-06-28 IL IL106158A patent/IL106158A0/xx unknown
- 1993-06-30 CA CA002138956A patent/CA2138956A1/en not_active Abandoned
- 1993-06-30 CN CN93109540A patent/CN1095382A/zh active Pending
- 1993-06-30 BR BR9306748A patent/BR9306748A/pt not_active Application Discontinuation
- 1993-06-30 JP JP6502660A patent/JPH08500821A/ja active Pending
- 1993-06-30 WO PCT/US1993/006238 patent/WO1994000125A1/en not_active Application Discontinuation
- 1993-06-30 RU RU94046378/04A patent/RU94046378A/ru unknown
- 1993-06-30 SI SI9300350A patent/SI9300350A/sl unknown
- 1993-06-30 AP APAP/P/1993/000542A patent/AP412A/en active
- 1993-06-30 CZ CZ943346A patent/CZ334694A3/cs unknown
- 1993-06-30 EP EP93915499A patent/EP0651643A4/en not_active Withdrawn
- 1993-06-30 HU HU9403833A patent/HUT69409A/hu unknown
- 1993-06-30 SK SK1599-94A patent/SK159994A3/sk unknown
- 1993-06-30 MX MX9303970A patent/MX9303970A/es unknown
- 1993-06-30 AU AU45459/93A patent/AU4545993A/en not_active Abandoned
-
1994
- 1994-12-29 OA OA60599A patent/OA10122A/en unknown
- 1994-12-29 KR KR1019940704802A patent/KR950702118A/ko not_active Application Discontinuation
- 1994-12-29 NO NO945074A patent/NO945074L/no unknown
- 1994-12-29 BG BG99313A patent/BG99313A/xx unknown
- 1994-12-30 FI FI946189A patent/FI946189A/fi not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114805462A (zh) * | 2018-02-11 | 2022-07-29 | 江苏豪森药业集团有限公司 | 一种甾族类衍生物调节剂及其制备方法和应用 |
CN114805462B (zh) * | 2018-02-11 | 2024-06-18 | 江苏豪森药业集团有限公司 | 一种甾族类衍生物调节剂及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CA2138956A1 (en) | 1994-01-06 |
GB9213835D0 (en) | 1992-08-12 |
EP0651643A4 (en) | 1995-10-04 |
AU4545993A (en) | 1994-01-24 |
ZA934645B (en) | 1994-01-25 |
MX9303970A (es) | 1994-04-29 |
FI946189A0 (fi) | 1994-12-30 |
IL106158A0 (en) | 1993-10-20 |
RU94046378A (ru) | 1996-10-10 |
KR950702118A (ko) | 1995-06-19 |
FI946189A (fi) | 1994-12-30 |
OA10122A (en) | 1996-12-18 |
SK159994A3 (en) | 1996-01-10 |
NO945074D0 (no) | 1994-12-29 |
CZ334694A3 (en) | 1995-10-18 |
NO945074L (no) | 1995-02-16 |
EP0651643A1 (en) | 1995-05-10 |
AP9300542A0 (en) | 1993-07-31 |
JPH08500821A (ja) | 1996-01-30 |
AP412A (en) | 1995-09-29 |
WO1994000125A1 (en) | 1994-01-06 |
HUT69409A (en) | 1995-09-28 |
BR9306748A (pt) | 1998-12-08 |
SI9300350A (sl) | 1993-12-31 |
MA22927A1 (fr) | 1994-04-01 |
BG99313A (en) | 1995-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1041054C (zh) | 含有甾类5-α-还原酶抑制剂的药物组合物制备方法 | |
CN1051181A (zh) | 芳族甾类5-α-还原酶抑制剂制备方法 | |
CN1061052C (zh) | 11β-芳基-4-雌烯及其药物上适宜的酸加成盐的制药应用 | |
CN1085223A (zh) | 17-β-取代的-4-氮杂-5α-雄烷-3-酮衍生物 | |
CN1234738A (zh) | 奥氮平二水合物d | |
CN1322130A (zh) | 抑制3型3α-羟基类固醇脱氢酶 | |
CN1906180A (zh) | 新的长效β-2-激动剂及其作为药物的用途 | |
CN1968924A (zh) | 作为β-分泌酶抑制剂用于治疗阿尔茨海默氏病的吡咯烷-3-基化合物 | |
CN1294577A (zh) | 钾通道抑制剂 | |
CN1085224A (zh) | 氟化17β-取代的4-氮杂-5α-雄甾烷-3-酮衍生物 | |
CN1129441A (zh) | 维生素d类似物 | |
CN1034207A (zh) | 新的药用甾体及其制备方法和中间体,以及含有这些甾体的药用组合物 | |
CN1036392C (zh) | 环取代的2-氨基四氢萘和3-氨基苯并二氢吡喃的制法 | |
CN1054856C (zh) | 取代的19-去甲甾类及其制备方法和药物组合物 | |
CN1081682A (zh) | 甾类衍生物 | |
CN1067057A (zh) | 不饱和的17β-取代的3-羧基甾族化合物的制备方法 | |
CN1105362A (zh) | 降低血清胆固醇的方法 | |
CN1993375A (zh) | 具有雄激素作用的甾类前药 | |
CN1134155A (zh) | 雄甾烯酮 | |
CN1095382A (zh) | 新的菁族a环甾族化合物 | |
CN1101916A (zh) | 17α和17β取代的酰基-3-羧基3,5-二烯甾族化合物 | |
CN1030921C (zh) | 制备δ4-甾类化合物的方法 | |
CN1501930A (zh) | 新的含有吡啶和环己烯基的吡咯并苯并二氮杂�羧酰胺和其衍生物;保胎催产素受体拮抗剂 | |
CN1326461A (zh) | 减数分裂调控化合物 | |
CN1751059A (zh) | 具有抗肿瘤活性的2-取代的雌-1,3,5(10)-三烯-3-基氨基磺酸酯 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |